PENPULIMAB KCQX- penpulimab injection 
Akeso Biopharma, Co., Ltd

----------

MEDICATION GUIDE

PENPULIMAB-KCQX (pen pul i mab kcqx)

injection

What is the most important information I should know about penpulimab-kcqx?

Penpulimab-kcqx is a medicine that may treat non-keratinizing nasopharyngeal cancer by working with your immune system. Penpulimab-kcqx can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.

Call or see your healthcare provider right away if you develop any new or worsening signs or symptoms, including:

Lung problems

  • cough
  • shortness of breath
  • chest pain

Intestinal problems

  • diarrhea (loose stools) or more frequent bowel movements than usual
  • stools that are black, tarry, sticky, or have blood or mucus
  • severe stomach-area (abdomen) pain or tenderness

Liver problems

  • yellowing of your skin or the whites of your eyes
  • dark urine (tea colored)
  • severe nausea or vomiting
  • bleeding or bruising more easily than normal
  • pain on the right side of your stomach-area (abdomen)

Hormone gland problems

  • headaches that will not go away or unusual headaches
  • urinating more often than usual
  • eye sensitivity to light
  • hair loss
  • eye problems
  • feeling cold
  • rapid heartbeat
  • constipation
  • increased sweating
  • your voice gets deeper
  • extreme tiredness
  • dizziness or fainting
  • weight gain or weight loss
  • changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness
  • feeling more hungry or thirsty than usual

Kidney problems

  • decrease in your amount of urine
  • swelling of your ankles
  • blood in your urine
  • loss of appetite

Skin problems

  • rash
  • painful sores or ulcers in your mouth or nose, throat, or genital area
  • itching
  • fever or flu-like symptoms
  • skin blistering or peeling
  • swollen lymph nodes

Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen with penpulimab-kcqx. Call or see your healthcare provider right away for any new or worsening signs or symptoms, which may include:

  • chest pain, irregular heartbeat, shortness of breath, swelling of ankles
  • confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs
  • double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight
  • persistent or severe muscle pain or weakness, muscle cramps
  • low red blood cells, bruising

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include:

  • chills or shaking
  • dizziness
  • itching or rash
  • feeling like passing out
  • flushing
  • fever
  • shortness of breath or wheezing
  • back pain

Rejection of a transplanted organ or tissue. Your healthcare provider should tell you what signs and symptoms you should report and monitor you depending on the type of organ or tissue transplant that you have had.

Complications, including graft-versus-host-disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with penpulimab-kcqx. Your healthcare provider will monitor you for these complications.

Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check for these problems during treatment with penpulimab-kcqx. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with penpulimab-kcqx if you have severe side effects.

What is penpulimab-kcqx?

Penpulimab-kcqx is a prescription medicine used to treat adults with a kind of cancer called non-keratinizing nasopharyngeal carcinoma (NPC).

  • Penpulimab-kcqx may be used in combination with either the chemotherapy medicines cisplatin or carboplatin and gemcitabine, as your first treatment when your non-keratinizing NPC has returned (recurrent) or has spread to other parts of your body (metastatic).
  • Penpulimab-kcqx may be used alone to treat your non-keratinizing NPC when it:
  • has spread (metastatic), and
  • you received chemotherapy that contains platinum and at least 1 other type of treatment, and it did not work or is no longer working.
It is not known if penpulimab-kcqx is safe and effective in children.

Before receiving penpulimab-kcqx, tell your healthcare provider about all of your medical conditions, including if you:

  • have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus
  • have received an organ transplant, including corneal transplant
  • have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic)
  • have received radiation treatment to your chest area
  • have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome
  • are pregnant or plan to become pregnant. Penpulimab-kcqx can harm your unborn baby.

Females who are able to become pregnant:

  • Your healthcare provider will give you a pregnancy test before you start treatment with penpulimab-kcqx.
  • You should use an effective method of birth control during your treatment and for 4 months after your last dose of penpulimab-kcqx. Talk to your healthcare provider about birth control methods that you can use during this time.
  • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with penpulimab-kcqx.
  • are breastfeeding or plan to breastfeed. It is not known if penpulimab-kcqx passes into your breast milk. Do not breastfeed during treatment with penpulimab-kcqx and for 4 months after your last dose of penpulimab-kcqx.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive penpulimab-kcqx?

  • Your healthcare provider will give you penpulimab-kcqx into your vein through an intravenous (IV) line over 60 minutes.
  • Penpulimab-kcqx is usually given every 2 or 3 weeks.
  • Your healthcare provider will decide how many treatments you need.
  • Your healthcare provider will test your blood to check you for certain side effects.
  • If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment.

What are the possible side effects of penpulimab-kcqx?

Penpulimab-kcqx can cause serious side effects. See “What is the most important information I should know about penpulimab-kcqx?”

The most common side effects of penpulimab-kcqx when used in combination with either cisplatin or carboplatin and gemcitabine include:

  • nausea
  • decreased appetite
  • feeling tired
  • vomiting
  • decreased weight
  • rash
  • low thyroid hormone levels
  • cough
  • fever
  • constipation
  • COVID-19 infection

The most common side effects of penpulimab-kcqx when used alone include low red blood cell count (anemia) and low thyroid hormone levels.

These are not all the possible side effects of penpulimab-kcqx.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of penpulimab-kcqx.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. You can ask your pharmacist or healthcare provider for information about penpulimab-kcqx that is written for healthcare professionals.

What are the ingredients in penpulimab-kcqx?

Active ingredient: penpulimab-kcqx

Inactive ingredients: acetic acid, polysorbate 80, sodium acetate, sorbitol, and Water for Injection.

Manufactured by: Akeso Biopharma Co., Ltd., 6 Shennong Road, Torch Development Zone, Zhongshan, Guangdong 528437, China

U.S. License No. xxxx

For more information, call 833-662-5376 or go to https://www.akesobio.com/en/.

This Medication Guide has been approved by the U.S. Food and Drug Administration. Issued: April/2025

Revised: 4/2025
Akeso Biopharma, Co., Ltd